Treatment of Hepatocellular Carcinoma (HCC)
DOI:
https://doi.org/10.59888/ajosh.v1i03.22Keywords:
Hepatocellular carcinoma, Treatment Status, Liver cancerAbstract
Hepatocellular carcinoma (HCC) or hepatoma is the most common type of primary liver cancer, followed by malignant lymphoma, fibrosarcoma, and hemangioendotelioma. In high-incidence areas, the most common cause is HBV transmitted at birth, and HCC is diagnosed about a decade earlier than in North America and Europe, where the most common etiology is HCV acquired later in life. This research uses the contrast review method, meaning the journal review method by finding differences between several research journals and then drawing conclusions, by taking several research journals that use the same sample but different research methods, different reagents used or different data applications used. In this study it was concluded that Hepatocellular carcinoma (HCC) or hepatoma is the most common type of primary malignant tumor of the liver. Hepatitis B and C infection, alcohol, aflatoxin B1, illicit drugs, cirrhosis, obesity, and diabetes mellitus are all risk factors for HCC.
References
Asafo-Agyei, K. O., & Samant, H. (2022). Hepatocellular Carcinoma [M]. StatPearls. Treasure Island (FL). StatPearls Publishing Copyright.
Balogh, J., Victor III, D., Asham, E. H., Burroughs, S. G., Boktour, M., Saharia, A., Li, X., Ghobrial, R. M., & Monsour Jr, H. P. (2016). Hepatocellular carcinoma: a review. Journal of Hepatocellular Carcinoma, 41–53.
Bosman, F. T., Carneiro, F., Hruban, R. H., & Theise, N. D. (2010). WHO classification of tumours of the digestive system. (Issue Ed. 4). World Health Organization.
Coppola, M., van den Eeden, S. J. F., Robbins, N., Wilson, L., Franken, K. L. M. C., Adams, L. B., Gillis, T. P., Ottenhoff, T. H. M., & Geluk, A. (2018). Vaccines for leprosy and tuberculosis: opportunities for shared research, development, and application. Frontiers in Immunology, 9, 308.
Di Tommaso, L., Franchi, G., Park, Y. N., Fiamengo, B., Destro, A., Morenghi, E., Montorsi, M., Torzilli, G., Tommasini, M., & Terracciano, L. (2007). Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis. Hepatology, 45(3), 725–734.
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer, 136(5), E359–E386.
Hafez, B., Osman, B., Chami, J., Ahmad, J. H., Ataya, K., & Khalife, M. J. (2022). Management of ruptured hepatocellular carcinoma invading the gastrointestinal tract: A case report. International Journal of Surgery Case Reports, 96, 107330.
Hennedige, T., & Venkatesh, S. K. (2013). Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring. Cancer Imaging: The Official Publication of the International Cancer Imaging Society, 12, 530–547.
Jasirwan, C. O. M., Fahira, A., Siregar, L., & Loho, I. (2020). The alpha-fetoprotein serum is still reliable as a biomarker for the surveillance of hepatocellular carcinoma in Indonesia. BMC Gastroenterology, 20(1), 1–8.
Jemal, A., Ward, E. M., Johnson, C. J., Cronin, K. A., Ma, J., Ryerson, A. B., Mariotto, A., Lake, A. J., Wilson, R., & Sherman, R. L. (2017). Annual report to the nation on the status of cancer, 1975–2014, featuring survival. JNCI: Journal of the National Cancer Institute, 109(9), djx030.
Kamarajah, S. K., Frankel, T. L., Sonnenday, C., Cho, C. S., & Nathan, H. (2018). Critical evaluation of the American Joint Commission on Cancer (AJCC) staging system for patients with Hepatocellular Carcinoma (HCC): a Surveillance, Epidemiology, End Results (SEER) analysis. Journal of Surgical Oncology, 117(4), 644–650.
Lotfollahzadeh, S., Recio-Boiles, A., & Babiker, H. M. (2017). Liver cancer.
Mittal, S., & El-Serag, H. B. (2013). Epidemiology of HCC: consider the population. Journal of Clinical Gastroenterology, 47, S2.
Ogunwobi, O. O., Harricharran, T., Huaman, J., Galuza, A., Odumuwagun, O., Tan, Y., Ma, G. X., & Nguyen, M. T. (2019). Mechanisms of hepatocellular carcinoma progression. World Journal of Gastroenterology, 25(19), 2279.
Singal, A. G., Lampertico, P., & Nahon, P. (2020). Epidemiology and surveillance for hepatocellular carcinoma: New trends. Journal of Hepatology, 72(2), 250–261.
Tortora, G. J., & Derrickson, B. H. (2012). Principles of Anatomy and Physiology, 2012. Hoboken: John Wiley & Sons.
Tseng, T., Liu, C., Yang, H., Su, T., Wang, C., Chen, C., Kuo, S. F., Liu, C., Chen, P., & Chen, D. (2012). High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. Gastroenterology, 142(5), 1140–1149.
Tunissiolli, N. M., Castanhole-Nunes, M. M. U., Biselli-Chicote, P. M., Pavarino, É. C., da Silva, R. F., & Goloni-Bertollo, E. M. (2017). Hepatocellular carcinoma: a comprehensive review of biomarkers, clinical aspects, and therapy. Asian Pacific Journal of Cancer Prevention: APJCP, 18(4), 863.
Waghray, A., Murali, A. R., & Menon, K. V. N. (2015). Hepatocellular carcinoma: from diagnosis to treatment. World Journal of Hepatology, 7(8), 1020.
Waller, L. P., Deshpande, V., & Pyrsopoulos, N. (2015). Hepatocellular carcinoma: A comprehensive review. World Journal of Hepatology, 7(26), 2648.
Wee, A. (2011). Fine-needle aspiration biopsy of hepatocellular carcinoma and related hepatocellular nodular lesions in cirrhosis: controversies, challenges, and expectations. Pathology Research International, 2011.
European Association For The Study Of The Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236.
World Health Organization. International Agency for Research on Cancer: Indonesia. 2020.
Setiati S. Internal Medicine. 7th ed. Jakarta: Interna Publishing; 2017
Indonesian Association of Liver Researchers. Hepatocellular Carcinoma [Internet]. PPHI. 2017 [cited 2022 Jul 11]. p. 1. Available from: https://www.pphi-online.org/alpha/
International Consensus Group for Hepatocellular Neoplasia. Pathologic Diagnosis of Early HepatocellularCarcinoma: A Report of the International ConsensusGroup for Hepatocellular Neoplasia. Hepatology. 2019;49(2):658–64.
Bosman F, Carneiro F, Hruban R TN. WHO classification of tumours. Lyon Int Agency Res Cancer. 2012;1(1):1–20.
World Health Organization. Hepatitis B vaccines. Weakly Epidemiol Rec. 2019;84(40):405–20.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 christian martin, Haleyoan Sofinia, Muhammad viky, Rokibullah Rokibullah
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International. that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
